“…Furthermore, HB‐EGF, COX‐2, and Wnt4 as well as Bmp2 have been shown to be risk factors for sex hormone‐dependent diseases, such as prostatic hyperplasia, breast cancer, and ovarian cancer (Bentley et al , 1992; Ferrandina et al , 2002; Levin, 2003; Zong et al , 2012). Since LPA 3 is highly expressed in the prostate, mammary gland, and ovary (Bandoh et al , 1999), LPA 3 signaling might contribute to the progression of such diseases.…”